Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

NCT00840684 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: amsacrine
DRUG: busulfan
DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: laromustine
DRUG: melphalan
DRUG: mitoxantrone hydrochloride
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: autologous hematopoietic stem cell transplantation

Sponsor

Institut Paoli-Calmettes